In diseases linked to FAD deficiency or disrupted riboflavin metabolism, like L-2-HGA and AIFM1-related encephalopathy, aberrant chromatin states and DNA methylation patterns have been observed, underscoring a tight connection between riboflavin availability and gene expression regulation. This evidence concerns the gene AIFM1 and Encephalopathy.